Approx. Rs 4,500 / VialGet Latest Price
Product Details:
| Strength | 150 mg |
| Physical Form | Concentrate for Injection |
| Drug Type | Biosimilar |
| Brand | (ELEFTHA, HERVYCTA+, TRUMAB, TRASTUREL, HERTRAZ, VIVITRA) |
| Treatment | HER2-Positive Cancers |
| Storage Temperature | 2-8 degree c |
| Packaging Type | Single-Use Vial |
| Composition | Trastuzumab |
Trastuzumab 150 mg Injection is a monoclonal antibody used in the treatment of HER2-positive breast cancer and gastric cancer. It works by specifically targeting the HER2 receptor, thereby inhibiting the growth and spread of cancer cells. Available with D Vijay Pharma Pvt Ltd for export markets. Bulk quantities and regular supplies can be arranged.
Keywords: Trastuzumab 150 mg Injection, Trastuzumab Injection, HER2 Positive Breast Cancer Injection, Monoclonal Antibody Injection, Anti-Cancer Injection, Oncology Medicines Exporter, Trastuzumab Supplier India, Trastuzumab Manufacturer, Trastuzumab Lyophilized Powder, Cancer Injection Supplier, Breast Cancer Drug, WHO-GMP Oncology Products, Trastuzumab 150 mg Vial, Pharmaceutical Exporter India, Oncology Injectable.
Additional Information:
Packaging Details: Sterile single-dose vial packed in a sealed glass vial with rubber stopper and flip-off cap. Each vial is placed in an individual printed carton with product insert. Cold-chain is maintained using insulated thermal packaging with gel packs to ensure temperature control during transit.